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Abstract: Bisphenol A (BPA) is a synthetic compound widely used for the production of polycarbonate
plasticware and epoxy resins. BPA exposure is widespread and more than 90% of individuals have
detectable amounts of the molecule in their body fluids, which originates primarily from diet. Here,
we investigated whether prenatal exposure to BPA affects the mevalonate (MVA) pathway in rat
brain fetuses, and whether potential effects are sex-dependent. The MVA pathway is important for
brain development and function. Our results demonstrate that the fetal brain, exposed in utero to a
very low dose of BPA (2.5 µg/kg/day), displayed altered MVA pathway activation, increased protein
prenylation, and a decreased level of pro-BDNF. Interestingly, the BPA-induced effects on estrogen
receptor α were sex-dependent. In conclusion, this work demonstrates intergenerational effects of
BPA on the brain at very low doses. Our results reveal new targets for BPA-induced interference and
underline the impacts of BPA on health.
Keywords: bisphenol A; cholesterol; 3-Hydroxy 3-methylglutaryl Coenzyme A reductase; mevalonate
pathway; neurotrophins
1. Introduction
Bisphenol A (BPA) is a synthetic compound that is widely used to produce polycarbonate plastic
and epoxy resins [1]. It is present in many consumer products including food and beverage containers,
thermal receipt paper, medical devices, cosmetics, and toys. In industrialized countries, BPA exposure
is widespread and more than 90% of individuals have detectable amount of BPA in their body fluids,
with exposure resulting primarily from diet [2]. BPA is a widely recognized endocrine disruptor that
interferes with estrogen and androgen receptor (ER and AR respectively) function, as well as with
thyroid hormone receptors (TR) [3]. BPA has a plethora of dangerous effects on human health, which
are tissue-specific and depend on onset, dose, and duration of exposure [3]. In this context, developing
fetuses are especially vulnerable to BPA exposure, even at very low doses. Considerable levels of
BPA are detected in placenta tissue, amniotic fluid, and fetal plasma. This is alarming since it is well
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established that BPA is able to cross the placenta and the blood brain barrier (BBB), thus affecting fetal
brain development and function [4,5]. Studies performed on primary cell cultures from prenatally
exposed rodents revealed that BPA reduces the proliferation of pluripotent neural progenitors and
alters the neuronal/glial progenitor ratio [6,7]. Similarly, several studies reported the disruption of
neurogenesis and neuronal migration in the embryonic mouse brain after maternal exposure [8,9].
Moreover, BPA may have a powerful influence on dimorphic brain differentiation mainly through its
well-characterized estrogenic [3] and antiandrogenic [3,10] activities. Among their multiple functions,
estrogens modulate cholesterol homeostasis [11–13]. Accordingly, there is increasing evidence that
BPA affects hepatic cholesterol levels by altering the expression of proteins involved in cholesterol
biosynthesis, possibly through the activation of estrogen receptors [14].
Cholesterol biosynthesis starting with the mevalonate (MVA) pathway plays a key role in the
brain, and its dysfunction has been related to neurodevelopmental disorders [15,16]. Cholesterol has
different structural roles in the brain: it is an important constituent of neuronal membranes and a
major component of the myelin sheath surrounding axons [17]. Notably, cholesterol is essential for the
formation, shape, and release of synaptic vesicles and determines the organization and positioning
of neurotransmitter receptors [18,19]. Besides cholesterol, other MVA pathway end-products play
essential roles in the brain. For instance, prenyls are required for the post-translational modification of
small GTPases, which are involved in crucial neurobiological functions. Protein prenylation involves
the covalent binding of farnesyl pyrophosphate (FPP) or geranylgeranyl pyrophosphate (GGPP)
moieties to proteins, allowing their translocation to cell membranes and, in turn, the activation of key
signaling cascades [20,21]. Ras proteins, a family of farnesylated proteins, mediate a plethora of signal
transduction pathways controlling cell proliferation and differentiation. Moreover, Ras modulates
processes related to learning, memory and behavioral responses that involve rearrangements of
synaptic connectivity [20–22]. RhoA is a geranylgeranylated G protein that controls gene transcription
and actin cytoskeleton remodeling and regulates neurite outgrowth and synaptic connectivity [23,24].
Furthermore, active RhoA suppresses the activation of cAMP responsive element binding protein
1 (CREB1). This key transcription factor controls memory, neurogenesis, neuron survival and
trophism [20], as it regulates levels of neurotrophic factors, such as brain-derived neurotrophic factor
(BDNF) and nerve growth factor (NGF) [25,26].
The key and rate-limiting enzyme of the MVA pathway is the 3-hydroxy-3-methylglutaryl
CoA reductase (HMGCR) [21]. Its activity is tightly regulated. Short-term regulation is based on
phosphorylation and de-phosphorylation, mainly through AMP activated kinase (AMPK) and protein
phosphatase 2A (PP2A), respectively [27,28]. Long-term regulation affects the protein levels through
transcription and degradation [29]. Transcription is controlled by the sterol regulatory element binding
protein 2 (SREBP2), which responds to changes in intracellular sterol level as part of a negative feedback
mechanism [30]. Apart from enzymes involved in cholesterol biosynthesis, SREBP2 also controls the
transcription of genes encoding the proteins involved in cholesterol transport and uptake, such as
low-density lipoprotein receptor (LDLr) [29–31].
Despite the importance of the MVA pathway and cholesterol homeostasis for brain development
and function, the effects of prenatal exposure to BPA on these key metabolic processes have not been
studied. Our study reveals specific intergenerational and sex-dependent defects in the fetal brain
induced by low doses of BPA.
2. Materials and Methods
2.1. Animals
All experiments were carried out in accordance with the European Guidelines for the care and use
of laboratory animals (Directive 26/2014/EU), and they were approved by the local ethical committee of
the University of Calabria and by the Italian Ministry of Health (license n.74/2018-PR). Experiments
were performed on female Sprague Dawley rats at 8 weeks of age. Rats were divided into four groups
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treated with BPA (Sigma Aldrich, Milan, Italy) at 2.5 µg/kg/day or 25 µg/kg/day or 250 µg/kg/day, or
BPA vehicle. BPA was administered to rats via drinking water. The factual intake was determined
based on the daily difference of drinking water volume and body weight gain. Control rats were
treated with 0.05% ethanol (BPA vehicle) corresponding to the highest amount of ethanol present in
the drink water of our rats treated with BPA. BPA or ethanol were administered for one month (virgin
state) plus 20 days during pregnancy. A female in proestrus was placed with a fertile male overnight.
A vaginal smear to detect spermatozoa was performed the following morning to confirm day 1 of
pregnancy. All rats were housed individually in the animal care facility, maintained under controlled
conditions on a 12-h light/dark photoperiod and provided commercial chow and tap water ad libitum.
Animals were euthanized on the 20th day of pregnancy with isoflurane inhalation, and the uterus
was removed. Blood was collected in 1 mL tubes and serum was allowed to clot at room temperature
for 30 min, then centrifuged at 2000× g for 10 min, at 4 ◦C. After the centrifugation, the serum was
carefully collected for the following analyses.
Fetuses removed from the uterus were collected in a beaker containing physiological solution,
HEPES-PSS, at 4 ◦C. The first two fetuses starting from the cervix end of one horn were used for
our analyses. The fetuses were placed in Petri dishes containing HEPES-PSS (4 ◦C) to determine the
gender and to isolate the brain. The sex of the fetus was determined on the base of the ano-urethra
distance evaluated using a stereomicroscope. In males, the distance between anus and urethra is about
1.5–2 times longer than in females. In addition, we confirmed the sex by examination of the genitals.
Fetal brains were dissected immediately after decapitation, the skull was gently opened by surgical
scissors and the brain was quickly removed and stored at −80 ◦C.
2.2. Cholesterol, HDL, LDL, and Triglyceride Content
Triglycerides and total-, LDL- and HDL-cholesterol were measured by means of an enzymatic
method (Cobas Integra 400 Plus, Roche Diagnostics, Rotkreuz, Switzerland), with intra- and inter-assay
coefficients of variation < 2%. The cholesterol amount in brain tissue was quantified by the Cholesterol
Quantitation Kit-MAK043 (Sigma Aldrich, Milan, Italy) following the manufacturer’s instructions.
2.3. Total Lysate and Membranes Preparation for Western Blot Analysis
Brain samples were lysed in 1:5 w/v homogenization buffer (Sucrose 0.1 M, KCl 0.05 M, KH2PO4
0.04 M, EDTA 0.04 M, pH 7.4, with 1:1000 protease inhibitor cocktail and 1:400 phosphatase inhibitor
cocktail, Sigma-Aldrich) by sonication (VCX 130 PB, Sonics, Newtown, 06,470 CT) on ice, for 30 s, and
centrifuged at 10,000 rpm for 10 min, at 4 ◦C to yield total lysate. To isolate membrane fractions, total
lysate was centrifuged at 14,000 rpm for 1 h at 4 ◦C and the pellet was solubilized in homogenization
buffer by sonication. Protein concentration was assessed by the method of Lowry [32]. Aliquots of
homogenate samples were diluted with Laemmli buffer, boiled for 5 min and subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for subsequent Western blot analysis.
2.4. Immunoblotting
Proteins (15 µg) from total lysates were separated by SDS-PAGE at 50 mA (constant current) first,
and then at 120 V for 120 min. Subsequently, proteins were transferred to nitrocellulose membranes
through Trans-Blot Turbo Transfer System (Bio-Rad Laboratories). The nitrocellulose membrane was
incubated at room temperature with 5% fat-free milk in Tris-buffered saline (NaCl 0.138 M, KCl 0.027
M, Tris-HCl 0.025 M, and 0.05% Tween-20, pH 6.8), and then overnight, at 4 ◦C, with primary antibody,
followed by 1 h of incubation with secondary peroxidase-conjugated antibody produced in mouse or
in rabbit (1:10,000; Biorad). Immunoreactivity was detected using the clarity ECL Western blotting
system (Bio-Rad Laboratories) and a ChemiDoc MP system (Bio-Rad Laboratories). The following
primary antibodies were tested: HMGCR (Abcam, ab242315, dilution 1:1000), P-HMGCR Ser872
(Merck Millipore, #09-356, dilution 1:1000), P-AMPK Thr172 (Sigma-Aldrich, #15-115, dilution 1:1000),
RhoA (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-418, dilution 1:500); Ras (Santa Cruz
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Biotechnology, sc-53959, dilution 1:500), P-CREB-1 Ser133 (Santa Cruz Biotechnology, sc-7978, dilution
1:1000), LDLr (Abcam, ab30532, dilution 1:1000), nSREBP2 (Abcam, ab30682, dilution 1:1000), BDNF
(Santa Cruz Biotechnology, sc-546, dilution 1:1000), NGF (Santa Cruz Biotechnology, sc-365944, dilution
1:2000), P-Akt Ser473 (Cell Signalling, 193H12, dilution 1:500), ERα (D12) (Santa Cruz Biotechnology,
sc-8005, dilution 1:1000), P-ERα Ser118 (Cell Signalling, 16J4, dilution 1:1000). As loading control,
the immunoblots were reacted with an antibody against tubulin, actin, or vinculin (1:10,000; Sigma
Aldrich, Milan, Italy). Western blot images were analyzed by ImageJ (National Institutes of Health,
Bethesda, MD, USA) software for Windows. Intensities of proteins of interest were normalized to
intensities of respective housekeeping proteins.
2.5. Statistical Analyses
Data are expressed as mean ± SD for all experiments. The experiments were performed in
duplicate (technical replicates) and at least six animals per experimental group were used (biological
replicates). Statistically significant differences were tested by one-way ANOVA for dams’ weight and
plasma lipids and by two-way analysis of variance (ANOVA), followed by Bonferroni post-hoc test
for all the other tests (p < 0.05 level). Statistical analyses and graph editing were performed using
GRAPHPAD Prism6 (GraphPad, La Jolla, CA, USA) for Windows.
3. Results
To uncover direct effects of BPA on the brain, we first tested whether the substance affected
metabolic parameters of the dams which could impair embryo development indirectly. BPA had no
effect on the weight of pregnant rats (Figure 1) or their plasma lipid profiles (Table 1).
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medium dose (25 µg/kg/day) showed no effect whereas the highest dose tested (250 µg/kg/day) 
Figure 1. Dams’ weight after BPA exposure. Pregnant rats were exposed to three different doses of
BPA (2.5- 25- 250 µg/kg/day) or vehicle (CTR) via drinking water, starting 30 days before the beginning
of pregnancy until their sacrifice at GD 20. Weights were measured at the end of the experiments.
Statistical analysis was carried out by one-way ANOVA. n = 7 for each experimental group.
Table 1. Plasma lipid content in dams drinking vehicle or BPA.
mg/dl Plasma CTR Vehicle BPA 2.5 µg/kg/day BPA 25 µg/kg/day BPA 250 µg/kg/day
Cholesterol 88.0 ± 14.4 70.8 ± 17.4 75.6 ± 14.1 83.4 ± 14.2
HDL 61.3 ± 10.9 46.0 ± 12.2 49.4 ± 12.6 59.7 ± 12.7
LDL 16.5 ± 9.4 10.0 ± 2.5 11.9 ± 2.3 12.7 ± 2.4
Triglycerides 299.7 ± 104.9 366.2 ± 142.0 341.4 ± 70.7 342.7 ± 2.5
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the brain of ale and fe ale rat fetuses. The ratio bet een the total a ount of R and of its
phosphorylated for reflects the activation state of the enzy e in pathophysiological contexts [24].
Prenatal exposure to BP odulated R activation in a dose- and sex-dependent anner. o
differences bet een sexes ere observed in control ani als. Specifically, BP significantly increased
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HMGCR activation at the lowest dose (2.5 µg/kg/day) in both male and female fetuses. Differently, a
medium dose (25 µg/kg/day) showed no effect whereas the highest dose tested (250 µg/kg/day) affected
only males, but not females (Figure 2). These results are in agreement with the well-established notions
that endocrine disruptors induce biological effects by U-shaped dose–response curves [3] and that,
sometimes, males but not females show non-monotonic dose–response curves in certain tests [33].
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Based on these results, we evaluated the involvement of AMPK, which is the main upstream 
kinase regulating HMGCR. As AMPK activation depends on the phosphorylation of its catalytic 
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exposure suppressed AMPK phosphorylation in both male and female fetuses, which fits well with 
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Figure 2. Activation state of HMGCR in the brain of rat fetuses in utero exposed to different doses
of BPA. On the left, HMGCR activation state in male (M, blue) and female (F, pink) fetuses of dams
exposed to three different doses of BPA (2.5- 25- 250 µg/kg/day) The substance was administered
through drinking water starting 30 days before the beginning of pregnancy until their sacrifice at GD 20.
HMGCR activation state was estimated by the ratio of total and phosphorylated form of the enzyme
and normalized to the values of the vehicle-treated animals. Tubulin served as housekeeping protein to
correct for protein loading. n = 6 for each experimental group. Images on the right show representative
Western blots. Statistical analysis was carried out by two-way ANOVA followed by Bonferroni post-hoc
test among the sample treated with the same dose. @ = p < 0.001 vs. sex-matched CTR; §§§ = p < 0.001
between male and female.
At present, it is unclear whether exposure to low-dose BPA is detrimental to human health,
especially when it is below the tolerable daily intake (4 µg/kg/day) indicated by the European Food
Safety Authority (EFSA). To address this topic, all following experiments were performed with
2.5 µg/kg/day BPA. As shown in Figure 3a and b respectively, the activation state of HMGCR did not
depend on alteration of its levels but was induced by a decrease in its phosphorylation [30].
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Figure 3. HMGCR total and phosphorylation levels in the brain of rat fetuses in utero exposed to
2.5 µg/kg/day of BPA. Representative western blot and densitometric analysis of total HMGCR (a)
and P-HMGCR (b). n = 6 for each experimental group. Tubulin served as housekeeping protein to
normalize protein loading. Statistical analysis was carried out by using two-way ANOVA followed by
Bonferroni post-hoc test. *** = p < 0.001 vs. CTR M; ### = p < 0.001 vs. CTR F.
Based on these results, we evaluated the involvement of AMPK, which is the main upstream
kinase r gulating HMGCR. As AMPK activation depends n the phosphorylation of its catalytic
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subunit [27], so the phosphorylation state of AMPK was analyzed. As shown in Figure 4, BPA exposure
suppressed AMPK phosphorylation in both male and female fetuses, which fits well with the low
P-HMGCR levels detected in exposed fetuses. 
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protein to normalize protein loading. n = 6 for each experimental group. Statistical analysis was 
carried out by using two-way ANOVA followed by Bonferroni post-hoc test. * = p < 0.05 vs. CTR M; 
## = p< 0.01 vs. CTR F. 
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extracellular uptake. The latter process is mainly operated by LDLr, which mediates the 
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the LDLr level was higher in female fetuses compared to males under normal conditions (Figure 5a). 
BPA exposure increased its levels in both male and female fetuses. To uncover the mechanisms 
underlying this change, both the negative post-translational regulator of LDLr, PCSK9 [34] and its 
transcription factor (the nuclear active fragment of SREBP2 (nSREBP2)) were analyzed. BPA exposure 
reduced the level of PCSK9 (Figure 5c) without affecting the level of nSREBP2 (Figure 5b), which is 
in also good agreement with the unmodified levels of HMGCR which is also a SREBP2 target gene. 
Notably, the modulation of PCSK9 occurred in a sex-dependent manner similar to LDLr. 
 
Figure 5. LDLr, nSREBP2 and PCSK9 content in the brain of rat fetuses in utero exposed to 2.5 
µg/kg/day of BPA. Representative Western blot and densitometric analysis of LDLr (a), nSREBP2 (b) 
and PCSK9 levels (c). n = 6 for each experimental group. Tubulin or vinculin served as housekeeping 
proteins. Statistical analysis was carried out by using two-way ANOVA followed by Bonferroni post-
hoc test. * = p < 0.05 vs. CTR M; *** = p < 0.001 vs. CTR M; ### = p < 0.001 vs. CTR F. 
Having analyzed the principal proteins involved in cholesterol synthesis and uptake, we then 
measured downstream products of the MVA pathway. Our results show that the cholesterol content 
in the brain of rat fetuses was not affected by BPA prenatal exposure (Table 2). 
Table 2. Brain cholesterol content in prenatal BPA- or Vehicle-exposed rat fetuses. 
Figure 4. AMPK phosphorylation in the brain of rat fetuses in utero exposed to 2.5 µg/kg/day of BPA.
Representative western blot and densitometric analysis of P-AMPK. Tubulin served as housekeeping
protein to normalize protein loading. n = 6 for each experimental group. Statistical analysis was carried
out by using two-way ANOVA followed by Bonferroni post-hoc test. * = p < 0.05 vs. CTR M; ## = p <
0.01 vs. CTR F.
Cholesterol homeostasis is strictly based on an adequate balance between biosynthesis and
extracellular uptake. The latter process is mainly operated by LDLr, which mediates the internalization
of LDL through receptor-mediated endocytosis [17,29]. Our results demonstrate that the LDLr level
was higher in female fetuses compared to males under normal conditions (Figure 5a). BPA exposure
increased its levels in both male and female fetuses. To uncover the mechanisms underlying this
change, both the negative post-translational regulator of LDLr, PCSK9 [34] and its transcription factor
(the nuclear active fragment of SREBP2 (nSREBP2)) were analyzed. BPA exposure reduced the level of
PCSK9 (Figure 5c) without affecting the level of nSREBP2 (Figure 5b), which is in also good agreement
with the unmodified levels of HMGCR which is also a SREBP2 target gene. Notably, the modulation of
PCSK9 occurred in a sex-dependent manner similar to LDLr.
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Figure 5. LDLr, nSREBP2 and PCSK9 content in the brain of rat fetuses in utero exposed to 2.5 µg/kg/day
of BPA. Representative Western blot and densitome ric an lysis of LDLr (a), nSREBP2 (b) and PCSK9
levels (c). n = 6 for each experimental group. Tubulin or vincul n served as housekeeping proteins.
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* = p < 0 05 vs. CTR M; *** = p < 0.001 vs. CTR M; ### = p < 0.001 vs. CTR F.
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Having analyzed the principal proteins involved in cholesterol synthesis and uptake, we then
measured downstream products of the MVA pathway. Our results show that the cholesterol content in
the brain of rat fetuses was not affected by BPA prenatal exposure (Table 2).
Table 2. Brain cholesterol content in prenatal BPA- or Vehicle-exposed rat fetuses.
CTR M BPA M CTR F BPA F
Cholesterol (mg/g tissue) 3.53 ± 1.1 4.39 ± 1.4 3.40 ± 1.4 4.80 ± 1.9
Besides cholesterol, the MVA pathway also produces isoprenoid intermediates (FPP and GGPP),
which regulate the subcellular location and activity of intracellular small G-proteins [20]. As these key
molecular switches orchestrate neuronal survival and plasticity, activated membrane-bound RhoA and
Ras were analyzed as prototypes of geranyl-geranylated and farnesylated proteins, respectively. BPA
enhanced both RhoA and Ras membrane translocation, which is in full agreements with the enhanced
HMGCR activity (Figure 6).
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(Figure 7b). Remarkably, these changes occurred in male and female fetuses. CREB1 represents one 
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Figure 6. RhoA and Ras activation in the brain of rat fetuses in utero exposed to 2.5 µg/kg/day of BPA.
Representative Western blots of membrane-bound RhoA (a) and Ras (b) and their content in total lysate
of fetuses brain from prenatally BPA exposed and CTR animals. The graphs represent the ratio of
membrane-bound and total levels of the proteins in brain lysates. n = 6 for each experimental group.
Statistical analysis was carried out by using two-way ANOVA followed by Bonferroni post-hoc test.
** = p < 0.01 vs. CTR M; *** = p < 0.001 vs. CTR M; # = p < 0.05 vs. CTR F; ## = p < 0.01 vs. CTR F.
A key signal regulating neuronal development is BDNF [20]. Previous studies revealed that a
high dose of BPA (200 µg/k /day) affects BDNF gene expression [35] which may compromise brain
development. We observed that even a low dose of this compound was sufficient t reduce the level
of pr -BDNF by 30% (Figure 7a), while no alterations were observed in the am unt of pro-NGF
(Figure 7b). Remarkably, thes changes occurred in male and femal fetuses. CREB1 represents one of
the main transcription factor that re ulates th expression of n urotrophin [20,36,37]. How ver, ur
analysis revealed no effect of BPA on th phosphorylation tatus of Akt and CREB1 following prenatal
exposure (Figure 7c, ).
We next test d whether BPA exerts its effects by disrupting ER signaling, which is the classic mode
of action of this compound and since it has been demonstrated that estrogens are able to modulate
cholesterol homeostasis. Interestingly, prenatal exposure to low doses of BPA exerted a sex-dependent
response by exclusively affecting male fetuses (Figure 8), suggesting that sex-independent effects were
mediated by distinct pathways.
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Figure 7. Pro-BDNF, Pro-NGF content, Akt and CREB1 phosphorylation in the brain of rat fetuses
in utero exposed to 2.5 µg/kg/day of BPA. Representative Western blot and densitometric analysis of
pro-BDNF (a) and pro-NGF levels (b), CREB-1 (c) and Akt phosphorylation (d) performed on brain
lysates from prenatally exposed to BPA and CTR animals. n = 6 for each experimental group. Vinculin
or actin served as housekeeping proteins. Statistical analysis was carried out by using two-way ANOVA
followed by Bonferroni post-hoc test. ** = p < 0.01 vs. CTR M; ## = p < 0.01 vs. CTR F.
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4. Discussion
According to the hypothesis of the fetal origin of adult diseases, stressors derived from the mother
“permanently change the body’s structure and function in ways which program the appearance of
disease in later life” [38]. In fact, prenatal development is a critical window of elevated vulnerability,
where the individual is particularly sensitive to environmental stressors. Notably, the brain represents
one of the most vulnerable organs in our body. A hallmark of brain development is the high capacity
of adaptation through the continuous adjustment of neuron number, balancing neurogenesis and
apoptosis, and neuronal connectivity, through the formation and elimination of synapses. These
processes operate within a remarkably complex and highly dynamic network, which is guided by
genetic and epigenetic signals and adapts to changes in the environment. On the other hand, this
plasticity renders the brain structure highly vulnerable to external environmental factors, including diet,
maternal behavior, and xenocompounds [39]. Several reports highlighted that cholesterol homeostasis
is required for the correct development and fu ction of the nervous system [19,21,22]. Co sequently,
alterations in th s m tabolic pathway during fetal development m y contribute to specific pathological
conditions, including eurodevelopmental and eurodegenerative diseases [15,16,18,40]. In the present
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work, we studied the effects of a low dose of BPA on the MVA pathway in fetal rat brains, but also
other key molecules that can be involved in brain development. Notably, the dose we used is below
the threshold indicated by EFSA (4 µg/kg/day). Our results demonstrate that BPA induces HMGCR
activation and enhances LDLr expression without any change in total cholesterol content. However,
we cannot exclude local or cell-specific changes. The data could suggest that the BPA-induced effects
on MVA pathway are mediated by post-translational mechanisms. Indeed, the expression of the
nuclear and transcriptionally active fragment of SREBP2 was unaltered upon BPA prenatal exposure,
which may exclude transcriptional changes of HMGCR and LDLr levels. On the other hand, BPA
inhibited AMPK phosphorylation, which in turn results in a lower phosphorylation rate of HMGCR.
The increase of LDLr levels may be caused by a reduced degradation rate modulated by PCSK9 [34].
The increase of HMGCR activity can also increase the content of other MVA end-products such as
prenyls and may enhance the level of protein prenylation. This was indicated by our observation
that BPA prenatal exposure significantly increased the amount of membrane-associated RhoA and
RAS. These small GTPases are involved in numerous signal transduction pathway whose balance
between activation/inactivation allows the central nervous system to develop and function properly.
For instance, RAS participates in the control of cell proliferation and morphology, as well as synaptic
connectivity mechanisms [20,22]. Similarly, RhoA supports integrating extracellular and intracellular
signals to coordinate actin cytoskeleton remodeling. Several reports highlight the critical role of
MVA pathway and RhoA in neurite formation and synaptic connectivity [24,27]. Notably, RhoA
activity has been related to neurite retraction [41], whereas its decrease has been associated to neurite
elongation [23,24]. Moreover, other researches demonstrate that prenylation is increased in several
neurological diseases [42]. So, BPA-induced alterations of this key regulatory proteins could perturb
brain development and functions.
Our results also demonstrate that BPA reduced the levels of neurotrophin precursor pro-BDNF.
BDNF and NGF are synthetized as precursors (pro-BDNF and pro-NGF respectively), which represent
the predominant neurotrophin forms present in different neuronal tissues [43,44]. BPA may lower bdnf
gene transcription through epigenetic deregulation. It is known that this endocrine disruptor affects
DNA methylation of transcriptionally relevant region of bdnf gene [35]. This hypothesis is supported
by previous findings that BPA treatment significantly decreases BDNF mRNA levels [45]. Interestingly,
BPA did not affect the Akt/CREB1 axis in our experimental context suggesting that BPA-induced
modulation of pro-BDNF levels is independent from this transduction pathway and, possibly, from
MVA pathway. However, it cannot be excluded that pro-BDNF changes may be associated to other
MVA pathway-dependent signaling cascades that are not evaluated in this work. The different behavior
of pro-BDNF and pro-NGF expression suggests independent mechanisms of regulation mediated
by BPA exposure. Our results support other studies, as the expression of these neurotrophins can
be subjected to diverse regulations by the same stimuli [46–48]. Finally, as BPA is primary known
as endocrine disruptor, we evaluated its impact on ERα phosphorylation. The phosphorylation on
Ser118 has profound effects on receptor activity, as it influences the recruitment of co-activators that
enhance ER-mediated gene transcription [49,50]. Interestingly, BPA prenatal exposition affected ERα
phosphorylation in male but not in female fetuses. This result suggests that males are more vulnerable
to this endocrine disruptor than females [33]. The effect of BPA on P-ERα levels is not unexpected since
BPA is structurally similar to estradiol, and thus it is able to bind ERα, inducing its phosphorylation
and configuration change [3], the reason why female seems to be less vulnerable in this context needs
further investigations. Moreover, previous reports indicated that BPA-dependent estrogenic activity
flows through the small pool of ERα localized at the plasma membrane which mediates rapid signal
transduction events [51,52]; thus, the post-translational modulation of MVA-related proteins, at least
in males, could also depend on the ERα-dependent signaling at the plasma membrane-starting signals.
Overall, the results presented herein underline that even very low doses of BPA in pregnant
drinking water can perturb key metabolic and signaling pathways in a sex-dependent and -independent
manner (Figure 9). Notably, these effects occur despite the efficient drug-metabolizing system of
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dams [4]. The effects of BPA may be due to the efficient placental transfer of both BPA and its
glucuronide derivative, coupled to the deficiency of fetal UDP glucuronosyltransferase (UGT) enzyme,
which eliminates xenobiotic substances [4]. Combined, these factors permit a remarkable amount
of active BPA in the fetal compartment. Subsequently, the substance can easily enter the central
nervous system as it can cross the blood-brain barriers [3,5,8]. In conclusion, this work demonstrates
an intergenerational effect of a very low dose of BPA on metabolic and signaling pathways that are
important for proper brain development and function, thus underlining the potential dangers for
human health.
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